ARCHIVES

In Brief: FDA’s Burlington Moves to Wyeth-Ayerst; NAS Award to Beckman; Genetics Online

This article is from The Cancer Letter archive.

Vol. 25 No. 05 | February 5, 1999

Download PDF Visit The Full Archive

Related Articles

Epstein Petition Seeks Broder’s Removal As NCI Director

February 5, 1993

NCI-Approved Clinical Trials Listed For April 2001

May 25, 2001

House and Senate Appropriators Pledge to Increase Biomedical Research Funding.

March 5, 1999

ESAs Increase Risk of Death by 11 Percent, Blood Clots by 59 Percent, Meta-Analysis Finds; Study To Be Updated At ASCO.

June 1, 2007

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

Mouse Strains For Retrovirus Research Available From NCU

March 23, 1984